# IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact

> **NCT04221815** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Medstar Health Research Institute** · enrollment: 3100 (estimated)

## Conditions studied

- Atherosclerosis

## Interventions

- **DEVICE:** Eagle Eye Platinum digital IVUS catheter with optional SyncVision
- **DEVICE:** Resolute Onyx Drug Eluting Stent
- **DEVICE:** Onyx Frontier Drug Eluting Stent
- **DEVICE:** Onyx TruStar Drug Eluting Stent
- **DEVICE:** Onyx TruCor Drug Eluting Stent

## Key facts

- **NCT ID:** NCT04221815
- **Lead sponsor:** Medstar Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-10-14
- **Primary completion:** 2026-09
- **Final completion:** 2027-09
- **Target enrollment:** 3100 (ESTIMATED)
- **Last updated:** 2025-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04221815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04221815, "IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04221815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*